2 studies found for:    23830355 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Not yet recruiting Safety and Efficacy of Fixed Dose Combination Dolutegravir/Abacavir/Lamivudine FDC Initiated During Acute HIV Infection
Conditions: HIV;   Acute HIV Infection
Intervention: Drug: DTG/3TC/ABC FDC
2 Active, not recruiting
Has Results
A Study of GSK1349572 Versus Raltegravir (RAL) With Investigator Selected Background Regimen in Antiretroviral-Experienced, Integrase Inhibitor-Naive Adults
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: GSK1349572;   Drug: Raltegravir;   Drug: GSK1349572 Placebo;   Drug: Raltegravir Placebo

Indicates status has not been verified in more than two years